These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8098564)

  • 1. Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: an immunohistochemical study.
    Schiffer D; Chiò A; Giordana MT; Pezzulo T; Vigliani MC
    Acta Neuropathol; 1993; 85(5):495-502. PubMed ID: 8098564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The growth potential of ependymomas with varying grades of malignancy measured by the Ki-67 labelling index and mitotic index.
    Schröder R; Ploner C; Ernestus RI
    Neurosurg Rev; 1993; 16(2):145-50. PubMed ID: 8345908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
    Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
    Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferating cell nuclear antigen (PCNA): expression in samples of human astrocytic gliomas.
    Revesz T; Alsanjari N; Darling JL; Scaravilli F; Lane DP; Thomas DG
    Neuropathol Appl Neurobiol; 1993 Apr; 19(2):152-8. PubMed ID: 8100356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
    Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters.
    Harper ME; Glynne-Jones E; Goddard L; Wilson DW; Matenhelia SS; Conn IG; Peeling WB; Griffiths K
    Prostate; 1992; 20(3):243-53. PubMed ID: 1374182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis.
    Maeda K; Chung YS; Onoda N; Kato Y; Nitta A; Arimoto Y; Yamada N; Kondo Y; Sowa M
    Cancer; 1994 Feb; 73(3):528-33. PubMed ID: 7905361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma.
    Ng IO; Lai EC; Fan ST; Ng M; Chan AS; So MK
    Cancer; 1994 May; 73(9):2268-74. PubMed ID: 7513246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma.
    Oda Y; Hashimoto H; Takeshita S; Tsuneyoshi M
    Cancer; 1993 Jul; 72(2):478-85. PubMed ID: 8100481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p14ARF protein (FL-132) immunoreactivity in intracranial ependymomas and its prognostic significance: an analysis of 103 cases.
    Korshunov A; Golanov A; Timirgaz V
    Acta Neuropathol; 2001 Sep; 102(3):271-7. PubMed ID: 11585252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in gynecological tumors and their related lesions].
    Sawada M; Ueda G; Inoue M; Shimizu H; Ogawa H; Nakazawa A; Fujita M; Tanizawa O; Tsujimoto M
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):181-7. PubMed ID: 1347557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferating cell nuclear antigen and S phase fraction in endometrial stromal sarcoma.
    Schofield JB; Mansi J; Camplejohn RS; Lane DP; Fisher C
    J Clin Pathol; 1992 Aug; 45(8):664-7. PubMed ID: 1357005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Correlation with mitotic count and clinical outcome.
    Amin MB; Ma CK; Linden MD; Kubus JJ; Zarbo RJ
    Am J Clin Pathol; 1993 Oct; 100(4):428-32. PubMed ID: 8105676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
    Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
    Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens.
    Ma CK; De Peralta MN; Amin MB; Linden MD; Dekovich AA; Kubus JJ; Zarbo RJ
    Am J Clin Pathol; 1997 Dec; 108(6):641-51. PubMed ID: 9384445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms.
    Karamitopoulou E; Perentes E; Melachrinou M; Maraziotis T
    Acta Neuropathol; 1993; 85(3):316-22. PubMed ID: 7681617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
    Lipponen PK; Eskelinen MJ
    Br J Cancer; 1992 Jul; 66(1):171-6. PubMed ID: 1353364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
    Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining.
    Aaltomaa S; Lipponen P; Syrjänen K
    Anticancer Res; 1992; 12(4):1281-6. PubMed ID: 1380227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
    Lee CS
    Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.